P. Warde et al., PROGNOSTIC FACTORS FOR RELAPSE IN STAGE-I TESTICULAR SEMINOMA TREATEDWITH SURVEILLANCE, The Journal of urology, 157(5), 1997, pp. 1705-1709
Purpose: We sought to identify prognostic factors predictive of diseas
e progression in patients with clinical stage I seminoma on surveillan
ce following orchiectomy. Materials and Methods: Between January 1981
and December 1993, 201 patients 20 to 86 years old (median age 34) wit
h clinical stage I seminoma were placed on surveillance following orch
iectomy. The potential prognostic factors studied included age, tumor
size, mitotic count, S phase fraction, ploidy, presence of small vesse
l invasion, syncytiotrophoblasts and tumor infiltrating lymphocytes, e
xpression of beta-human chorionic gonadotropin and low molecular weigh
t keratin on immunohistochemistry. Results: With a median followup of
6.1 years (range 1.3 to 12.3) 31 patients had relapse for an actuarial
5-year relapse-free rate of 84.9%. The 5-year actuarial survival rate
was 97.1% and the cause specific survival rate was 99.5%. On univaria
te analysis factors predictive of relapse were tumor size (5-year rela
pse-free rate 88 and 67% for tumors 6 cm. or less and greater than 6 c
m., respectively, p = 0.004), age (5-year relapse-free rate 79 and 91%
for age 34 years or younger versus older than 34 years, respectively,
p = 0.009) and presence of small vessel invasion (5-year relapse-free
rate 86 versus 69%, p = 0.01). On multivariate analysis age and tumor
size were predictive of relapse, while small vessel invasion approach
ed statistical significance. The risk of relapse in 57 patients with n
one of the 3 adverse prognostic factors (age greater than 34 years, tu
mor 6 cm. or smaller and no small vessel invasion) was 6%. Conclusions
: We identified age, size of the primary tumor and small vessel invasi
on as important prognostic factors for relapse in patients with stage
I seminoma treated with surveillance. Further followup and assessment
of biological factors are needed to optimize selection of patients at
a high risk for relapse who should receive immediate postoperative the
rapy.